Literature DB >> 18048489

The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during catalysis.

Yan Xiong1, Anne-Sisko Patana, Michael J Miley, Agnieszka K Zielinska, Stacie M Bratton, Grover P Miller, Adrian Goldman, Moshe Finel, Matt R Redinbo, Anna Radominska-Pandya.   

Abstract

All UDP-glucuronosyltransferase enzymes (UGTs) share a common cofactor, UDP-glucuronic acid (UDP-GlcUA). The binding site for UDP-GlcUA is localized to the C-terminal domain of UGTs on the basis of amino acid sequence homology analysis and crystal structures of glycosyltransferases, including the C-terminal domain of human UGT2B7. We hypothesized that the (393)DQMDNAK(399) region of human UGT1A10 interacts with the glucuronic acid moiety of UDP-GlcUA. Using site-directed mutagenesis and enzymatic analysis, we demonstrated that the D393A mutation abolished the glucuronidation activity of UGT1A10 toward all substrates. The effects of the alanine mutation at Q(394),D(396), and K(399) on glucuronidation activities were substrate-dependent. Previously, we examined the importance of these residues in UGT2B7. Although D(393) (D(398) in UGT2B7) is similarly critical for UDP-GlcUA binding in both enzymes, the effects of Q(394) (Q(399) in UGT2B7) to Ala mutation on activity were significant but different between UGT1A10 and UGT2B7. A model of the UDP-GlcUA binding site suggests that the contribution of other residues to cosubstrate binding may explain these differences between UGT1A10 and UGT2B7. We thus postulate that D(393) is critical for the binding of glucuronic acid and that proximal residues, e.g., Q(394) (Q(399) in UGT2B7), play a subtle role in cosubstrate binding in UGT1A10 and UGT2B7. Hence, this study provides important new information needed for the identification and understanding of the binding sites of UGTs, a major step forward in elucidating their molecular mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18048489      PMCID: PMC2275115          DOI: 10.1124/dmd.107.016469

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  18 in total

Review 1.  Structural and functional studies of UDP-glucuronosyltransferases.

Authors:  A Radominska-Pandya; P J Czernik; J M Little; E Battaglia; P I Mackenzie
Journal:  Drug Metab Rev       Date:  1999-11       Impact factor: 4.518

2.  Importance of histidine residues for the function of the human liver UDP-glucuronosyltransferase UGT1A6: evidence for the catalytic role of histidine 370.

Authors:  M Ouzzine; L Antonio; B Burchell; P Netter; S Fournel-Gigleux; J Magdalou
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

Review 3.  Structures and mechanisms of glycosyltransferases.

Authors:  Christelle Breton; Lenka Snajdrová; Charlotte Jeanneau; Jaroslav Koca; Anne Imberty
Journal:  Glycobiology       Date:  2005-07-21       Impact factor: 4.313

4.  The importance of cysteine 126 in the human liver UDP-glucuronosyltransferase UGT1A6.

Authors:  Claire Senay; Gabriele Jedlitschky; Nadège Terrier; Brian Burchell; Jacques Magdalou; Sylvie Fournel-Gigleux
Journal:  Biochim Biophys Acta       Date:  2002-05-20

5.  Kinetic characterization of the 1A subfamily of recombinant human UDP-glucuronosyltransferases.

Authors:  Leena Luukkanen; Jyrki Taskinen; Mika Kurkela; Risto Kostiainen; Jouni Hirvonen; Moshe Finel
Journal:  Drug Metab Dispos       Date:  2005-03-31       Impact factor: 3.922

6.  Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than other UGTs and was purified as an active dimeric enzyme.

Authors:  Mika Kurkela; J Arturo García-Horsman; Leena Luukkanen; Saila Mörsky; Jyrki Taskinen; Marc Baumann; Risto Kostiainen; Jouni Hirvonen; Moshe Finel
Journal:  J Biol Chem       Date:  2002-11-14       Impact factor: 5.157

7.  The human UDP-glucuronosyltransferase: identification of key residues within the nucleotide-sugar binding site.

Authors:  Anne-Sisko Patana; Mika Kurkela; Adrian Goldman; Moshe Finel
Journal:  Mol Pharmacol       Date:  2007-06-19       Impact factor: 4.436

8.  Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases.

Authors:  Tiia Kuuranne; Mika Kurkela; Mario Thevis; Wilhelm Schänzer; Moshe Finel; Risto Kostiainen
Journal:  Drug Metab Dispos       Date:  2003-09       Impact factor: 3.922

9.  Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7.

Authors:  Michael J Miley; Agnieszka K Zielinska; Jeffrey E Keenan; Stacie M Bratton; Anna Radominska-Pandya; Matthew R Redinbo
Journal:  J Mol Biol       Date:  2007-03-30       Impact factor: 5.469

10.  Opioids bind to the amino acids 84 to 118 of UDP-glucuronosyltransferase UGT2B7.

Authors:  Birgit L Coffman; William R Kearney; Shawn Goldsmith; Boyd M Knosp; Thomas R Tephly
Journal:  Mol Pharmacol       Date:  2003-02       Impact factor: 4.436

View more
  6 in total

1.  Identification of residues that confer sugar selectivity to UDP-glycosyltransferase 3A (UGT3A) enzymes.

Authors:  Robyn Meech; Anne Rogers; Lizhe Zhuang; Benjamin C Lewis; John O Miners; Peter I Mackenzie
Journal:  J Biol Chem       Date:  2012-05-23       Impact factor: 5.157

2.  Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases.

Authors:  Stacie M Bratton; Carrie M Mosher; Farid Khallouki; Moshe Finel; Michael H Court; Jeffery H Moran; Anna Radominska-Pandya
Journal:  J Pharmacol Exp Ther       Date:  2011-10-04       Impact factor: 4.030

3.  Role of human UDP-glucuronosyltransferases in the biotransformation of the triazoloacridinone and imidazoacridinone antitumor agents C-1305 and C-1311: highly selective substrates for UGT1A10.

Authors:  Barbara Fedejko-Kap; Stacie M Bratton; Moshe Finel; Anna Radominska-Pandya; Zofia Mazerska
Journal:  Drug Metab Dispos       Date:  2012-06-01       Impact factor: 3.922

4.  Identification of UDP glycosyltransferase 3A1 as a UDP N-acetylglucosaminyltransferase.

Authors:  Peter I Mackenzie; Anne Rogers; Joanna Treloar; Bo R Jorgensen; John O Miners; Robyn Meech
Journal:  J Biol Chem       Date:  2008-11-03       Impact factor: 5.157

Review 5.  The crystal structure of human UDP-glucuronosyltransferase 2B7 C-terminal end is the first mammalian UGT target to be revealed: the significance for human UGTs from both the 1A and 2B families.

Authors:  Anna Radominska-Pandya; Stacie M Bratton; Matthew R Redinbo; Michael J Miley
Journal:  Drug Metab Rev       Date:  2010-02       Impact factor: 4.518

6.  Integrate thermostabilized fusion protein apocytochrome b 562 RIL and N-glycosylation mutations: A novel approach to heterologous expression of human UDP-glucuronosyltransferase (UGT) 2B7.

Authors:  Jia Xue; Haitao Zhang; Su Zeng
Journal:  Front Pharmacol       Date:  2022-08-12       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.